Encompass Health Corporation Statistics
Share Statistics
Encompass Health Corporation has 100.75M shares outstanding. The number of shares has increased by 0.39% in one year.
Shares Outstanding | 100.75M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -0.06% |
Owned by Institutions (%) | n/a |
Shares Floating | 99.20M |
Failed to Deliver (FTD) Shares | 45 |
FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 1.02M, so 1.01% of the outstanding shares have been sold short.
Short Interest | 1.02M |
Short % of Shares Out | 1.01% |
Short % of Float | 1.03% |
Short Ratio (days to cover) | 1.63 |
Valuation Ratios
The PE ratio is 18.86 and the forward PE ratio is 21.47. Encompass Health Corporation's PEG ratio is 0.49.
PE Ratio | 18.86 |
Forward PE | 21.47 |
PS Ratio | 1.38 |
Forward PS | 1.7 |
PB Ratio | 4.03 |
P/FCF Ratio | 24.8 |
PEG Ratio | 0.49 |
Enterprise Valuation
Encompass Health Corporation has an Enterprise Value (EV) of 9.47B.
EV / Earnings | 26.9 |
EV / Sales | 1.97 |
EV / EBITDA | 9.24 |
EV / EBIT | 12.94 |
EV / FCF | 35.37 |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 1.44.
Current Ratio | 1.28 |
Quick Ratio | 1.28 |
Debt / Equity | 1.44 |
Total Debt / Capitalization | 58.95 |
Cash Flow / Debt | 0.36 |
Interest Coverage | 5.1 |
Financial Efficiency
Return on equity (ROE) is 0.21% and return on capital (ROIC) is 10.95%.
Return on Equity (ROE) | 0.21% |
Return on Assets (ROA) | 0.06% |
Return on Capital (ROIC) | 10.95% |
Revenue Per Employee | 174.71K |
Profits Per Employee | 12.81K |
Employee Count | 27.48K |
Asset Turnover | 0.79 |
Inventory Turnover | 0 |
Taxes
Income Tax | 132.20M |
Effective Tax Rate | 0.22 |
Stock Price Statistics
The stock price has increased by 49.9% in the last 52 weeks. The beta is 0.78, so Encompass Health Corporation's price volatility has been higher than the market average.
Beta | 0.78 |
52-Week Price Change | 49.9% |
50-Day Moving Average | 99.13 |
200-Day Moving Average | 88.95 |
Relative Strength Index (RSI) | 40.02 |
Average Volume (20 Days) | 656.37K |
Income Statement
In the last 12 months, Encompass Health Corporation had revenue of $4.80B and earned $352.00M in profits. Earnings per share was $3.54.
Revenue | 4.80B |
Gross Profit | 933.50M |
Operating Income | 731.80M |
Net Income | 352.00M |
EBITDA | 1.02B |
EBIT | 731.80M |
Earnings Per Share (EPS) | 3.54 |
Balance Sheet
The company has $69.10M in cash and $2.93B in debt, giving a net cash position of -$2.86B.
Cash & Cash Equivalents | 69.10M |
Total Debt | 2.93B |
Net Cash | -2.86B |
Retained Earnings | 406.50M |
Total Assets | 6.46B |
Working Capital | 36.50M |
Cash Flow
In the last 12 months, operating cash flow was $850.80M and capital expenditures -$583.10M, giving a free cash flow of $267.70M.
Operating Cash Flow | 850.80M |
Capital Expenditures | -583.10M |
Free Cash Flow | 267.70M |
FCF Per Share | 2.69 |
Margins
Gross margin is 19.44%, with operating and profit margins of 15.24% and 7.33%.
Gross Margin | 19.44% |
Operating Margin | 15.24% |
Pretax Margin | 12.65% |
Profit Margin | 7.33% |
EBITDA Margin | 21.34% |
EBIT Margin | 15.24% |
FCF Margin | 5.58% |
Dividends & Yields
EHC pays an annual dividend of $0.68, which amounts to a dividend yield of 0.69%.
Dividend Per Share | $0.68 |
Dividend Yield | 0.69% |
Dividend Growth (YoY) | 13.33% |
Payout Ratio | 16% |
Earnings Yield | 3.6% |
FCF Yield | 2.71% |
Analyst Forecast
The average price target for EHC is $110, which is 12% higher than the current price. The consensus rating is "Buy".
Price Target | $110 |
Price Target Difference | 12% |
Analyst Consensus | Buy |
Analyst Count | 9 |
Stock Splits
The last stock split was on Jul 1, 2022. It was a forward split with a ratio of 1257:1000.
Last Split Date | Jul 1, 2022 |
Split Type | forward |
Split Ratio | 1257:1000 |
Scores
Altman Z-Score | 3.03 |
Piotroski F-Score | 6 |